For all press and media enquiries please contact mediarelations@chiesi.com
The event brings together the company’s key partners to discuss the best practices in terms of quality, service level, innovation, collaboration and Chiesi’s value chain sustainability journey; The 2023 “Partner Awards” will be dedicated to entities that particularly distinguished themselves in two…
New research from Chiesi analyses the economic burden for 23 rare diseases across five therapeutic areas in three EU Member States and will be launched during a panel at the World Orphan Drug Congress (WODC) in Barcelona, Spain. The panel hosted by Chiesi is titled, ‘Reducing the burden of rare…
For the first time in the Foundation's history, a week of work and meetings with local authorities, hospital directors, doctors and nurses from Burundi, Burkina Faso, Togo, and Benin. The Foundation is active in the field of international health cooperation, through the transfer of scientific means…
A new survey, part of a report published by Economist Impact and supported by Chiesi, focuses on how respiratory patients experience the adverse effects of poor air quality. The report, result of a scoping literature review and survey, recognizes that climate-related factors have a significant…
Total of six poster presentations analyze the effects of treatment with enzyme replacement therapies in Fabry disease and alpha-mannosidosis; Company sponsoring symposium on advances in monitoring and management in Fabry disease. BOSTON (USA), September 1 st, 2023 – Chiesi Global Rare Diseases, a…
Chiesi Group announces mid-year turnover of €1,497 million; Substantial growth of each of Chiesi’s business areas; Europe remains the biggest market, followed by the US and China; Forecasted revenues of about €3 billion for 2023, with an additional solid growth expected in 2024. Parma (Italy), 3…
Chiesi’s Sustainability Report 2022 is released today; The company has committed to reaching Net Zero GHG emissions by 2035; 130,000 units of Chiesi medicines, valued at €4.5 million, were donated to patients in conflict territories; The company closed the gender pay gap at Group level, with an…
Alessandro Chiesi has held the post of Chief Commercial Officer since 2020, and succeeds Alberto Chiesi, who, together with his brother Paolo, led the Group to global expansion over the past five decades. Parma (Italy), July 7 th, 2023 – Chiesi announces the appointment of Alessandro Chiesi as Chair…
”Rare Land” is a movie by Eftimiz Hatzis, which gives the audience a front-row seat to understand the difficult experience of a family facing a rare disease, such as alpha-mannosidosis. Challenges in the early diagnosis of rare and ultra-rare diseases and opportunities to increasingly support…
You are leaving the Chiesi Corp site to access another Chiesi site. Regulatory constraints and medical practices, as well as the information published on the site you are about to visit, may change from one country to another and may not comply with current Italian legislation on the subject.
You are about to leave our website and access an external site. By continuing, you agree to leave our site.
